Medicare program opens access to obesity medications for seniors
The Hill · October 1, 2026Original source ↗
What happened
Over 600,000 Medicare beneficiaries have enrolled in the Medicare GLP-1 Bridge program since its launch, allowing eligible seniors improved access to obesity medications. The program is aimed at addressing obesity treatment among older adults.
Why it matters
This expansion in access to obesity medications is significant for public health among seniors.
How this story affects people
How does this story affect you if you are a Medicare beneficiary?
You now have expanded access to obesity medications that can help manage your health. This program aims to address obesity treatment specifically for seniors, potentially improving your overall well-being.
Read a briefing based on your profile
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Download on the App Store3 free Ripples in total. Read without an account. iPhone · iOS 26.0+ · United States
More stories
- HealthSupport for Medicare for All rises to 66 percent among U.S. adults
- HealthMeasles outbreak in Pennsylvania affects pregnancy care practices
- HealthKenya reports first Ebola case following death of man returning from DRC
- HealthU.S. Response to Potential Plague Threat in Russia Delayed by Missing Details